Literature DB >> 10430957

Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development.

D Vaudry1, B J Gonzalez, M Basille, A Fournier, H Vaudry.   

Abstract

High concentrations of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors are present in the external granule cell layer of the rat cerebellum during postnatal development. In vitro studies have shown that PACAP promotes cell survival and neurite outgrowth on immature cerebellar granule cells in primary culture. In the present study, we have investigated the effect of PACAP on the development of the cerebellar cortex of 8-day-old rats. Incubation of cultured granule cells for 12 or 18 h with PACAP provoked a significant increase in the rate of incorporation of [(3)H]thymidine in cultured granule cells, suggesting that PACAP could stimulate the proliferation of granule cells. After 96 h of treatment, in vivo administration of PACAP provoked a transient increase in the number of granule cells in the molecular layer and in the internal granule cell layer. In contrast, PACAP did not affect the number of Purkinje cells. The augmentation of the number of granule cells evoked by PACAP was significantly inhibited by the PACAP receptor antagonist PACAP(6-38). Administration of PACAP also caused a significant increase in the volume of the cerebellar cortex. The present study provides evidence that PACAP can act in vivo as a trophic factor during rat brain development. Our data indicate that PACAP increases proliferation and/or inhibits programmed cell death of granule cells, as well as stimulating neuronal migration from the external granule cell layer toward the internal granule cell layer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430957      PMCID: PMC17797          DOI: 10.1073/pnas.96.16.9415

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Expression of pituitary adenylate cyclase activating polypeptide receptors in the early mouse embryo as assessed by reverse transcription polymerase chain reaction and in situ hybridisation.

Authors:  W J Sheward; E M Lutz; A J Harmar
Journal:  Neurosci Lett       Date:  1996-09-20       Impact factor: 3.046

2.  Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells.

Authors:  A Hernandez; B Kimball; G Romanchuk; M W Mulholland
Journal:  Peptides       Date:  1995       Impact factor: 3.750

3.  Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: focus on pituitary adenylate cyclase activating polypeptide.

Authors:  N Wolf; K Krieglstein
Journal:  Neurosci Lett       Date:  1995-11-24       Impact factor: 3.046

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway.

Authors:  M Villalba; J Bockaert; L Journot
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

5.  TGF-beta-induced apoptosis of cerebellar granule neurons is prevented by depolarization.

Authors:  A de Luca; M Weller; A Fontana
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

6.  Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.

Authors:  S Cavallaro; A Copani; V D'Agata; S Musco; S Petralia; C Ventra; F Stivala; S Travali; P L Canonico
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

7.  Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study.

Authors:  H Hashimoto; H Nogi; K Mori; H Ohishi; R Shigemoto; K Yamamoto; T Matsuda; N Mizuno; S Nagata; A Baba
Journal:  J Comp Neurol       Date:  1996-08-05       Impact factor: 3.215

Review 8.  Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction.

Authors:  A Arimura; S Shioda
Journal:  Front Neuroendocrinol       Date:  1995-01       Impact factor: 8.606

9.  Pituitary adenylate cyclase-activating polypeptide activates different signal transducing mechanisms in cultured cerebellar granule cells.

Authors:  A Favit; U Scapagnini; P L Canonico
Journal:  Neuroendocrinology       Date:  1995-04       Impact factor: 4.914

10.  Local control of granule cell generation by cerebellar Purkinje cells.

Authors:  R J Smeyne; T Chu; A Lewin; F Bian; S Sanlioglu; S S-Crisman; C Kunsch; S A Lira; J Oberdick
Journal:  Mol Cell Neurosci       Date:  1995-06       Impact factor: 4.314

View more
  42 in total

1.  Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors.

Authors:  M Lee; V Lelievre; P Zhao; M Torres; W Rodriguez; J Y Byun; S Doshi; Y Ioffe; G Gupta; A E de los Monteros; J de Vellis; J Waschek
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.

Authors:  Andrew C Emery; Lee E Eiden
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

4.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

5.  Changes in the expression of PACAP-like compounds during the embryonic development of the earthworm Eisenia fetida.

Authors:  Akos Boros; Dora Reglodi; Zsofia Herbert; Gabor Kiszler; Jozsef Nemeth; Andrea Lubics; Peter Kiss; Andrea Tamas; Seiji Shioda; Kouhei Matsuda; Edit Pollak; Laszló Molnar
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

6.  Pituitary adenylyl cyclase-activating peptide counteracts hedgehog-dependent motor neuron production in mouse embryonic stem cell cultures.

Authors:  Megumi Hirose; Pawel Niewiadomski; Gary Tse; Gloria C Chi; Hongmei Dong; Alice Lee; Ellen M Carpenter; James A Waschek
Journal:  J Neurosci Res       Date:  2011-06-14       Impact factor: 4.164

7.  Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP).

Authors:  David Vaudry; Yun Chen; Aurélia Ravni; Carol Hamelink; Abdel G Elkahloun; Lee E Eiden
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

8.  Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult.

Authors:  David Vaudry; Carol Hamelink; Ruslan Damadzic; Robert L Eskay; Bruno Gonzalez; Lee E Eiden
Journal:  Peptides       Date:  2005-07-11       Impact factor: 3.750

9.  Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.

Authors:  Eszter Banki; Eszter Pakai; Balazs Gaszner; Csaba Zsiboras; Andras Czett; Paras Rahul Parkash Bhuddi; Hitoshi Hashimoto; Gabor Toth; Andrea Tamas; Dora Reglodi; Andras Garami
Journal:  J Mol Neurosci       Date:  2014-07-04       Impact factor: 3.444

10.  Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival.

Authors:  Victor May; Eve Lutz; Christopher MacKenzie; Kristin C Schutz; Kate Dozark; Karen M Braas
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.